BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home » Authors » Tamra Sami

Articles by Tamra Sami

Cochlear ordered to pay $268M to AMF in enhanced damages for patent infringement

Nov. 7, 2018
By Tamra Sami
PERTH, Australia – Australia's Cochlear Ltd. said it would fight a U.S. District Court patent infringement verdict reported Monday that doubles the damages Cochlear was ordered to pay the Alfred E. Mann Foundation for Scientific Research and Advanced Bionics LLC. The Federal District Court for the Central District of California awarded "enhanced damages" in the amount of $268 million, and the cochlear implant company will need to lodge a $335 million insurance bond to appeal the judgement.
Read More

Australia aims to become regenerative medicine hub for the Asia Pacific region

Nov. 7, 2018
By Tamra Sami
BRISBANE, Australia – Australia is considered one of the first movers in the regenerative medicine (RM) space, with more than 70 institutes and companies working in the sector across the country. But to capitalize on its technical capabilities, it will need to be strategic if it is to reach its potential to be a major player in Asia Pacific.
Read More

Australia maps out new CDx regulatory framework that mirrors EU regs

Nov. 7, 2018
By Tamra Sami
PERTH, Australia – Australia’s Therapeutic Goods Administration (TGA) is seeking industry comments on a proposal to introduce a new framework for companion diagnostics.
Read More

Australia aims to become regenerative medicine hub for the Asia Pacific region

Nov. 6, 2018
By Tamra Sami

Australia aims to become regenerative medicine hub for the Asia Pacific region

Nov. 6, 2018
By Tamra Sami
BRISBANE, Australia – Australia is considered one of the first movers in the regenerative medicine (RM) space, with more than 70 institutes and companies working in the sector across the country. But to capitalize on its technical capabilities, it will need to be strategic if it is to reach its potential to be a major player in Asia Pacific.
Read More

Australia maps out new CDx regulatory framework that mirrors EU regs

Nov. 1, 2018
By Tamra Sami
PERTH, Australia – Australia's Therapeutic Goods Administration (TGA) is seeking industry comments on a proposal to introduce a new framework for companion diagnostics.
Read More

Australia maps out new companion diagnostic regulatory framework that mirrors EU regs

Oct. 31, 2018
By Tamra Sami

Australia sets in motion mandatory requirements for patient implant cards

Oct. 25, 2018
By Tamra Sami

Australia launches first oncology registry trials

Oct. 24, 2018
By Tamra Sami
PERTH, Australia – Australia is kicking off its first-ever registry-based randomized controlled trials in oncology to help clinicians select the right treatments for the right patients.
Read More

Cochlear unveils plans to develop totally implantable device

Oct. 22, 2018
By Tamra Sami
Previous 1 2 … 194 195 196 197 198 199 200 201 202 … 226 227 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 9, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing